Use of hydroxyiminoalkanoic acids as anti-nitrous agents in operations of reductive stripping of plutonium
The use of hydroxyiminoalkanoic acids including at least four carbon atoms as anti-nitrous agents in operations of reductive stripping of plutonium. The invention may be useful in any method for processing spent nuclear fuels that includes one or more operations of reductive stripping of plutonium and, more particularly, in the PUREX method as implemented in modern nuclear fuel processing plants, as well as in processes derived therefrom.
1. A method of reductive stripping of plutonium from an organic non-water miscible phase comprising an extracting agent and plutonium at an oxidation state IV in an organic diluent, comprising:
contacting the organic phase with an aqueous phase comprising a reducing agent capable of reducing plutonium(IV) to plutonium(III) and nitric acid; then
separating the so contacted organic and aqueous phases;
wherein the organic phase or the aqueous phase further comprises at least one anti-nitrous agent, the antinitrous agent being a hydroxyiminoalkanoic acid of general formula O═C(OH)—(R)—CH═N—OH where R is a straight-chain or branched alkylene group having at least 2 carbon atoms.
2. The method of claim 1 , wherein R is an alkylene group having 2 to 12 carbon atoms.
3. The method of claim 2 , wherein R is a straight-chain alkylene group having 3 to 8 carbon atoms.
4. The method of claim 3 , wherein the hydroxyiminoalkanoic acid is 6 hydroxyiminohexanoic acid or 8-hydroxyiminooctanoic acid.
5. The method of claim 1 , wherein the extracting agent is a tri-n-alkyl phosphate.
6. The method of claim 5 , wherein the extracting agent is tri-n-butyl phosphate.
7. The method of claim 1 , wherein the reducing agent is uranium(IV), hydroxylammonium nitrate, alkylated derivatives of hydroxylamine, ferrous sulfamate or sulfamic acid.
8. The method of claim 7 , wherein the reducing agent is uranium(IV) or hydroxylammonium nitrate.
9. The method of claim 1 , wherein the aqueous phase comprises from 0.02 mol/L to 0.6 mol/L of the reducing agent.
10. The method of claim 9 , wherein the aqueous phase comprises from 0.05 mol/L to 0.4 mol/L of the reducing agent.
11. The method of claim 1 , wherein the organic phase or the aqueous phase comprises from 0.01 mol/L to 3 mol/L of the hydroxyminoalkanoic acid.
12. The method of claim 11 , wherein the organic phase or the aqueous phase comprises from 0.03 mol/L to 0.5 mol/L of the hydroxyminoalkanoic acid.
13. The method of claim 1 , which is implemented in a PUREX method or a COEX method.